ReviewOrphanet journal of rare diseases2025
Erythropoietic protoporphyria linked to intricate double heterozygous mutations in theFECH gene: a case report and literature review.
Review in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heme arginate improves acute liver failure secondary to erythropoietic protoporphyria: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundErythropoietic protoporphyria is an inherited disorder characterized by mutations in the FECH gene, which encodes the enzyme ferrous chelatase. These mutations disrupt normal heme synthesis, leading to the accumulation of protoporphyrin in erythrocytes and other tissues. Clinical manifestations include cutaneous photosensitivity, characterized by burning and itching of the skin, and, less commonly, liver failure. CASE DESCRIPTION: A teenager presented with abdominal pain, distention, and jaundice, along with a history of suspected photosensitivity. Lab tests revealed abnormal liver enzymes. Imaging showed liver cirrhosis. Liver biopsy confirmed bile accumulation and protoporphyrin deposits. Genetic testing identified a complex heterozygous mutation in the FECH gene, leading to a diagnosis of EPP.
resultsThe patient ultimately succumbed to complications arising from decompensated cirrhosis, specifically ruptured esophagogastric fundal varices and hepatorenal syndrome. We retrospectively reviewed 98 cases of EPP reported in English literature over the past decade (2014–2024). The overall mortality rate was 4.1% (4 patients).
conclusionPatients diagnosed with EPP may exhibit hepatic dysfunction as their primary clinical manifestation. In the evaluation of the etiology of liver dysfunction, EPP, a rare genetic disorder, should be considered. This case report describes a novel mutation in the FECH gene located at chr18-55226418 (c.763G > T, exon 7), thereby contributing to the expanding spectrum of known FECH gene mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.